查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1404655

质粒DNA製造市场规模、份额、趋势分析报告：依疾病、等级、应用、市场开拓阶段、地区、细分市场预测，2024-2030年

Plasmid DNA Manufacturing Market Size, Share & Trends Analysis Report By Disease (Cancer, Infectious Diseases), By Grade (R&D Grade, GMP Grade), By Application, By Development Phase, By Region, And Segment Forecasts, 2024 - 2030
出版日期: | 出版商: Grand View Research | 英文 110 Pages | 商品交期: 2-10个工作天内

价格

质粒 DNA 製造市场成长与趋势：

Grand View Research, Inc.最新报告显示，预计2024年至2030年全球质粒DNA製造市场规模将以21.01%的复合年增长率成长，2030年将达到67亿美元。

除了慢性病盛行率上升之外，质粒DNA在医疗保健产业的广泛应用预计将推动该产业的成长。质粒 DNA 可直接用于治疗应用，例如疫苗抗原的生产和基因治疗。此外，它还可用于各种研究目的，例如基因克隆和基因图谱。选择基因治疗的患者数量不断增加预计将在未来几年推动行业成长。

根据 ClinicalTrials.gov 的数据，全球管道计画（I 期至 III 期试验）的细胞和基因疗法数量从 2018 年的 289 种增加到 2022 年的 327 种。此外，美国FDA 持续透过与产品製造相关的多项政策支持先进治疗领域的创新。随着细胞和基因治疗产品的激增，该行业可能需要大规模生产质粒 DNA。 COVID-19 大流行预计将对行业成长产生积极影响。例如，2021 年 9 月，印度核准了第一个 COVID-19 DNA 疫苗。这是世界上第一个与 DBT-BIRAC 合作生产的世界上第一个 COVID-19 DNA 疫苗，作为 Mission COVID Suraksha 的一部分。

印度的 ZyCoV-D 疫苗接种中使用了环状 DNA，以预防 COVID-19 感染。此外，全球产业的主要企业正在采取各种策略措施来增加其在市场上的影响力，这也有望推动成长。例如，2022年6月，Biosina宣布在新的专用GMP套件中扩大质粒DNA生产，以提供CDMO服务。该套件具有高达 300L 的一次性发酵容量和适当规模的下游加工机械。

质粒 DNA 製造市场报告亮点

  • 2023 年 GMP 等级类型占据最大收益占有率。 GMP 级质粒 DNA 广泛用于基因治疗和疫苗接种的临床前测试，包括生物分布和毒性测试。
  • 由于质粒DNA在基因疫苗临床研究应用的重要性日益增加，临床治疗领域将在2023年主导全球产业。
  • 由于对治疗遗传疾病和病症的基因疗法的高需求，细胞和基因疗法应用将在 2023 年引领业界。
  • 由于医疗基础设施的改善、高可支配收入、大量从事先进疗法研发的中心和研究机构以及该地区先进疗法的采用率增加，北美将在 2023 年成为排名第一的地区。 。
  • 由于研发活动的活性化以及该领域主要企业的存在，预计亚太地区在预测期内的复合年增长率将是最快的。

目录

第一章调查方法与范围

第 2 章执行摘要

第三章市场变数、趋势和范围

  • 市场体系展望
    • 母市场展望
    • 相关/附随市场展望
  • 市场趋势及展望
  • 市场动态
    • 越来越多的患者选择基因治疗
    • 强大的基因治疗管道
    • 市场竞争激烈，市场相关人员采取不同的策略
    • 各种医学疗法对质粒 DNA 的需求不断增加
  • 市场抑制因素分析
    • 与基因治疗相关的监管、科学和伦理问题
  • 营商环境分析
    • PESTEL分析
    • 波特五力分析
    • COVID-19感染疾病的影响分析

第四章 年级业务分析

  • 全球质粒 DNA 製造市场：等级变化分析
  • 研发级
    • 研发级市场，2018-2030
  • GMP级
    • GMP 级市场，2018-2030

第五章 发展阶段业务分析

  • 全球质粒DNA製造市场：发展阶段变化分析
  • 临床前治疗
  • 临床治疗
  • 非处方治疗

第六章 应用业务分析

  • 全球质粒DNA製造市场：应用变化分析
  • DNA疫苗
    • DNA疫苗市场，2018-2030
  • 细胞和基因治疗
    • 细胞与基因治疗市场，2018-2030
  • 免疫疗法
    • 免疫治疗市场，2018-2030
  • 其他的
    • 其他市场，2018-2030

第七章疾病业务分析

  • 全球质粒DNA製造市场：疾病波动分析
  • 感染疾病
  • 癌症
  • 遗传疾病
  • 其他的

第八章区域业务分析

  • 2022年及2030年全球质粒DNA製造市场占有率（按地区）
  • 北美洲
    • 北美质粒 DNA 製造市场，2018-2030
    • 美国
    • 加拿大
  • 欧洲
    • 欧洲质粒DNA製造市场，2018-2030
    • 德国
    • 英国
    • 法国
    • 义大利
    • 西班牙
    • 丹麦
    • 瑞典
    • 挪威
  • 亚太地区
    • 亚太地区质粒 DNA 製造市场，2018-2030
    • 日本
    • 中国
    • 印度
    • 韩国
    • 澳洲
    • 泰国
  • 拉丁美洲
    • 拉丁美洲质粒 DNA 製造市场，2018-2030
    • 巴西
    • 墨西哥
    • 阿根廷
  • 中东/非洲
    • 中东和非洲质粒 DNA 製造市场，2018-2030
    • 南非
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 科威特

第9章竞争形势

  • 公司分类
  • 策略规划
  • 2022 年公司市场/职位占有率分析
  • 公司简介/名单
    • Charles River Laboratories
    • Danaher
    • VGXI, Inc.
    • Kaneka Corp.
    • Lonza
    • Nature Technology
    • Cell and Gene Therapy Catapult
    • Eurofins Genomics
    • Luminous BioSciences, LLC
    • Akron Biotech
Product Code: GVR-4-68039-977-1

Plasmid DNA Manufacturing Market Growth & Trends:

The global plasmid DNA manufacturing market size is expected to reach USD 6.70 billion by 2030, expanding at a CAGR of 21.01% from 2024 to 2030, according to a new report by Grand View Research, Inc. The rising prevalence of chronic diseases, combined with the wide application scope of plasmid DNA in the healthcare industry is expected to drive the industry growth. Plasmid DNA can be used directly for therapeutic applications, such as the production of vaccine antigens or gene therapy. Moreover, it can be utilized for various research purposes, such as gene cloning, gene mapping, etc. The rising number of patients choosing gene therapy is expected to drive industry growth in the coming years.

According to clinicaltrials.gov, the number of cell & gene therapies across global pipeline programs (Phase I to Phase III trials) increased from 289 in 2018 to 327 in 2022. Furthermore, the U.S. FDA provides constant support for innovations in the advanced therapy arena via several policies concerning product manufacturing. With increased cell and gene therapy products, the industry will see an increased need for manufacturing plasmid DNA on a larger scale. The COVID-19 pandemic is anticipated to positively impact industry growth. For instance, in September 2021, India approved the first COVID-19 DNA vaccine. It is the world's first COVID-19 DNA vaccine manufactured in partnership with DBT-BIRAC as part of Mission COVID Suraksha.

Circular DNA is used in India's ZyCoV-D vaccination to protect against COVID-19 infection. Furthermore, key entities in the global industry are undertaking various strategic initiatives to strengthen their market presence, which is also expected to propel growth. For instance, in June 2022, BioCina announced the expansion of the production of plasmid DNA in a new dedicated GMP suite to its offering of CDMO services. The suite has a single-use fermentation capacity of up to 300 L and appropriately scaled downstream processing machinery.

Plasmid DNA Manufacturing Market Report Highlights:

  • The GMP grade type segment held the largest revenue share in 2023. GMP-grade plasmid DNAs are broadly utilized in pre-clinical trials in gene therapy or vaccination including biodistribution and toxicology studies
  • The clinical therapeutics segment dominated the global industry in 2023 owing to the increased importance of plasmid DNA for clinical research applications in genetic vaccination
  • The cell & gene therapy application segment led the industry in 2023 owing to the high demand for gene therapy for the treatment of several inherited diseases and genetic disorders
  • North America was the dominant regional market in 2023 due to improved healthcare infrastructure, high disposable income, presence of a substantial number of centers and institutes that are engaged in R&D of advanced therapies, and increased adoption of advanced therapies in the region
  • Asia Pacific is anticipated to register the fastest CAGR during the forecast years on account of the increasing R&D activities in this field and the presence of key players

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation and Scope
  • 1.2. Market Definitions
    • 1.2.1. Information analysis
    • 1.2.2. Market formulation & data visualization
    • 1.2.3. Data validation & publishing
  • 1.3. Information Procurement
    • 1.3.1. Primary Others
  • 1.4. Information or Data Analysis
  • 1.5. Market Formulation & Validation
  • 1.6. Market Model
  • 1.7. Objectives
    • 1.7.1. Objective 1
    • 1.7.2. Objective 2

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Snapshot
  • 2.3. Competitive Landscape Snapshot

Chapter 3. Market Variables, Trends, & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent Market Outlook
    • 3.1.2. Related/Ancillary Market Outlook
  • 3.2. Market Trends and Outlook
  • 3.3. Market Dynamics
    • 3.3.1. Increasing number of patients opting for gene therapy
    • 3.3.2. Robust pipeline for gene therapies
    • 3.3.3. Highly competitive market and various strategies undertaken by market players
    • 3.3.4. Increasing demand for plasmid DNA in various medical therapies
  • 3.4. Market Restraint Analysis
    • 3.4.1. Regulatory, Scientific, And Ethical Challenges Associated With Gene Therapy
  • 3.5. Business Environment Analysis
    • 3.5.1. PESTEL Analysis
    • 3.5.2. Porter's Five Forces Analysis
    • 3.5.3. COVID-19 Impact Analysis

Chapter 4. Grade Business Analysis

  • 4.1. Global Plasmid DNA Manufacturing Market: Grade Movement Analysis
  • 4.2. R&D Grade
    • 4.2.1. R&D Grade Market, 2018 - 2030 (USD Million)
  • 4.3. GMP Grade
    • 4.3.1. GMP Grade Market, 2018 - 2030 (USD Million)

Chapter 5. Development Phase Business Analysis

  • 5.1. Global Plasmid DNA Manufacturing Market: Development Phase Movement Analysis
  • 5.2. Pre-Clinical Therapeutics
    • 5.2.1. Pre-Clinical Therapeutics Market, 2018 - 2030 (USD Million)
  • 5.3. Clinical Therapeutics
    • 5.3.1. Clinical Therapeutics Market, 2018 - 2030 (USD Million)
  • 5.4. Marketed Therapeutics
    • 5.4.1. Marketed Therapeutics Market, 2018 - 2030 (USD Million)

Chapter 6. Application Business Analysis

  • 6.1. Global Plasmid DNA Manufacturing Market: Application Movement Analysis
  • 6.2. DNA Vaccines
    • 6.2.1. DNA Vaccines Market, 2018 - 2030 (USD Million)
  • 6.3. Cell & Gene Therapy
    • 6.3.1. Cell & Gene Therapy Market, 2018 - 2030 (USD Million)
  • 6.4. Immunotherapy
    • 6.4.1. Immunotherapy Market, 2018 - 2030 (USD Million)
  • 6.5. Others
    • 6.5.1. Others Market, 2018 - 2030 (USD Million)

Chapter 7. Disease Business Analysis

  • 7.1. Global Plasmid DNA Manufacturing Market: Disease Movement Analysis
  • 7.2. Infectious Disease
    • 7.2.1. Infectious Disease Market, 2018 - 2030 (USD Million)
  • 7.3. Cancer
    • 7.3.1. Cancer Market, 2018 - 2030 (USD Million)
  • 7.4. Genetic Disorder
    • 7.4.1. Genetic Disorder Market, 2018 - 2030 (USD Million)
  • 7.5. Others
    • 7.5.1. Others Market, 2018 - 2030 (USD Million)

Chapter 8. Regional Business Analysis

  • 8.1. Global Plasmid DNA Manufacturing Market Share By Region, 2022 & 2030
  • 8.2. North America
    • 8.2.1. North America Plasmid DNA Manufacturing Market, 2018 - 2030 (USD Million)
    • 8.2.2. U.S.
      • 8.2.2.1. Key Country Dynamics
      • 8.2.2.2. Competitive Scenario
      • 8.2.2.3. Regulatory Framework
      • 8.2.2.4. Target Disease Prevalence
      • 8.2.2.5. U.S. Plasmid DNA Manufacturing Market, 2018 - 2030 (USD Million)
    • 8.2.3. Canada
      • 8.2.3.1. Key Country Dynamics
      • 8.2.3.2. Competitive Scenario
      • 8.2.3.3. Regulatory Framework
      • 8.2.3.4. Target Disease Prevalence
      • 8.2.3.5. Canada Plasmid DNA Manufacturing Market, 2018 - 2030 (USD Million)
  • 8.3. Europe
    • 8.3.1. Europe Plasmid DNA Manufacturing Market, 2018 - 2030 (USD Million)
    • 8.3.2. Germany
      • 8.3.2.1. Key Country Dynamics
      • 8.3.2.2. Competitive Scenario
      • 8.3.2.3. Regulatory Framework
      • 8.3.2.4. Target Disease Prevalence
      • 8.3.2.5. Germany Plasmid DNA Manufacturing Market, 2018 - 2030 (USD Million)
    • 8.3.3. UK
      • 8.3.3.1. Key Country Dynamics
      • 8.3.3.2. Competitive Scenario
      • 8.3.3.3. Regulatory Framework
      • 8.3.3.4. Target Disease Prevalence
      • 8.3.3.5. UK Plasmid DNA Manufacturing Market, 2018 - 2030 (USD Million)
    • 8.3.4. France
      • 8.3.4.1. Key Country Dynamics
      • 8.3.4.2. Competitive Scenario
      • 8.3.4.3. Regulatory Framework
      • 8.3.4.4. Target Disease Prevalence
      • 8.3.4.5. France Plasmid DNA Manufacturing Market, 2018 - 2030 (USD Million)
    • 8.3.5. Italy
      • 8.3.5.1. Key Country Dynamics
      • 8.3.5.2. Competitive Scenario
      • 8.3.5.3. Regulatory Framework
      • 8.3.5.4. Target Disease Prevalence
      • 8.3.5.5. Italy Plasmid DNA Manufacturing Market, 2018 - 2030 (USD Million)
    • 8.3.6. Spain
      • 8.3.6.1. Key Country Dynamics
      • 8.3.6.2. Competitive Scenario
      • 8.3.6.3. Regulatory Framework
      • 8.3.6.4. Target Disease Prevalence
      • 8.3.6.5. Spain Plasmid DNA Manufacturing Market, 2018 - 2030 (USD Million)
    • 8.3.7. Denmark
      • 8.3.7.1. Key Country Dynamics
      • 8.3.7.2. Competitive Scenario
      • 8.3.7.3. Regulatory Framework
      • 8.3.7.4. Target Disease Prevalence
      • 8.3.7.5. Denmark Plasmid DNA Manufacturing Market, 2018 - 2030 (USD Million)
    • 8.3.8. Sweden
      • 8.3.8.1. Key Country Dynamics
      • 8.3.8.2. Competitive Scenario
      • 8.3.8.3. Regulatory Framework
      • 8.3.8.4. Target Disease Prevalence
      • 8.3.8.5. Sweden Plasmid DNA Manufacturing Market, 2018 - 2030 (USD Million)
    • 8.3.9. Norway
      • 8.3.9.1. Key Country Dynamics
      • 8.3.9.2. Competitive Scenario
      • 8.3.9.3. Regulatory Framework
      • 8.3.9.4. Target Disease Prevalence
      • 8.3.9.5. Norway Plasmid DNA Manufacturing Market, 2018 - 2030 (USD Million)
  • 8.4. Asia Pacific
    • 8.4.1. Asia Pacific Plasmid DNA Manufacturing Market, 2018 - 2030 (USD Million)
    • 8.4.2. Japan
      • 8.4.2.1. Key Country Dynamics
      • 8.4.2.2. Competitive Scenario
      • 8.4.2.3. Regulatory Framework
      • 8.4.2.4. Target Disease Prevalence
      • 8.4.2.5. Japan Plasmid DNA Manufacturing Market, 2018 - 2030 (USD Million)
    • 8.4.3. China
      • 8.4.3.1. Key Country Dynamics
      • 8.4.3.2. Competitive Scenario
      • 8.4.3.3. Regulatory Framework
      • 8.4.3.4. Target Disease Prevalence
      • 8.4.3.5. China Plasmid DNA Manufacturing Market, 2018 - 2030 (USD Million)
    • 8.4.4. India
      • 8.4.4.1. Key Country Dynamics
      • 8.4.4.2. Competitive Scenario
      • 8.4.4.3. Regulatory Framework
      • 8.4.4.4. Target Disease Prevalence
      • 8.4.4.5. India Plasmid DNA Manufacturing Market, 2018 - 2030 (USD Million)
    • 8.4.5. South Korea
      • 8.4.5.1. Key Country Dynamics
      • 8.4.5.2. Competitive Scenario
      • 8.4.5.3. Regulatory Framework
      • 8.4.5.4. Target Disease Prevalence
      • 8.4.5.5. South Korea Plasmid DNA Manufacturing Market, 2018 - 2030 (USD Million)
    • 8.4.6. Australia
      • 8.4.6.1. Key Country Dynamics
      • 8.4.6.2. Competitive Scenario
      • 8.4.6.3. Regulatory Framework
      • 8.4.6.4. Target Disease Prevalence
      • 8.4.6.5. Australia Plasmid DNA Manufacturing Market, 2018 - 2030 (USD Million)
    • 8.4.7. Thailand
      • 8.4.7.1. Key Country Dynamics
      • 8.4.7.2. Competitive Scenario
      • 8.4.7.3. Regulatory Framework
      • 8.4.7.4. Target Disease Prevalence
      • 8.4.7.5. Thailand Plasmid DNA Manufacturing Market, 2018 - 2030 (USD Million)
  • 8.5. Latin America
    • 8.5.1. Latin America Plasmid DNA Manufacturing Market, 2018 - 2030 (USD Million)
    • 8.5.2. Brazil
      • 8.5.2.1. Key Country Dynamics
      • 8.5.2.2. Competitive Scenario
      • 8.5.2.3. Regulatory Framework
      • 8.5.2.4. Target Disease Prevalence
      • 8.5.2.5. Brazil Plasmid DNA Manufacturing Market, 2018 - 2030 (USD Million)
    • 8.5.3. Mexico
      • 8.5.3.1. Key Country Dynamics
      • 8.5.3.2. Competitive Scenario
      • 8.5.3.3. Regulatory Framework
      • 8.5.3.4. Target Disease Prevalence
      • 8.5.3.5. Mexico Plasmid DNA Manufacturing Market, 2018 - 2030 (USD Million)
    • 8.5.4. Argentina
      • 8.5.4.1. Key Country Dynamics
      • 8.5.4.2. Competitive Scenario
      • 8.5.4.3. Regulatory Framework
      • 8.5.4.4. Target Disease Prevalence
      • 8.5.4.5. Argentina Plasmid DNA Manufacturing Market, 2018 - 2030 (USD Million)
  • 8.6. MEA
    • 8.6.1. MEA Plasmid DNA Manufacturing Market, 2018 - 2030 (USD Million)
    • 8.6.2. South Africa
      • 8.6.2.1. Key Country Dynamics
      • 8.6.2.2. Competitive Scenario
      • 8.6.2.3. Regulatory Framework
      • 8.6.2.4. Target Disease Prevalence
      • 8.6.2.5. South Africa Plasmid DNA Manufacturing Market, 2018 - 2030 (USD Million)
    • 8.6.3. Saudi Arabia
      • 8.6.3.1. Key Country Dynamics
      • 8.6.3.2. Competitive Scenario
      • 8.6.3.3. Regulatory Framework
      • 8.6.3.4. Target Disease Prevalence
      • 8.6.3.5. Saudi Arabia Plasmid DNA Manufacturing Market, 2018 - 2030 (USD Million)
    • 8.6.4. UAE
      • 8.6.4.1. Key Country Dynamics
      • 8.6.4.2. Competitive Scenario
      • 8.6.4.3. Regulatory Framework
      • 8.6.4.4. Target Disease Prevalence
      • 8.6.4.5. UAE Plasmid DNA Manufacturing Market, 2018 - 2030 (USD Million)
    • 8.6.5. Kuwait
      • 8.6.5.1. Key Country Dynamics
      • 8.6.5.2. Competitive Scenario
      • 8.6.5.3. Regulatory Framework
      • 8.6.5.4. Target Disease Prevalence
      • 8.6.5.5. Kuwait Plasmid DNA Manufacturing Market, 2018 - 2030 (USD Million)

Chapter 9. Competitive Landscape

  • 9.1. Company Categorization
  • 9.2. Strategy Mapping
  • 9.3. Company Market/Position Share Analysis, 2022
  • 9.4. Company Profiles/Listing
    • 9.4.1. Charles River Laboratories
      • 9.4.1.1. Overview
      • 9.4.1.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 9.4.1.3. Product Benchmarking
      • 9.4.1.4. Strategic Initiatives
    • 9.4.2. Danaher
      • 9.4.2.1. Overview
      • 9.4.2.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 9.4.2.3. Product Benchmarking
      • 9.4.2.4. Strategic Initiatives
    • 9.4.3. VGXI, Inc.
      • 9.4.3.1. Overview
      • 9.4.3.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 9.4.3.3. Product Benchmarking
      • 9.4.3.4. Strategic Initiatives
    • 9.4.4. Kaneka Corp.
      • 9.4.4.1. Overview
      • 9.4.4.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 9.4.4.3. Product Benchmarking
      • 9.4.4.4. Strategic Initiatives
    • 9.4.5. Lonza
      • 9.4.5.1. Overview
      • 9.4.5.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 9.4.5.3. Product Benchmarking
      • 9.4.5.4. Strategic Initiatives
    • 9.4.6. Nature Technology
      • 9.4.6.1. Overview
      • 9.4.6.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 9.4.6.3. Product Benchmarking
      • 9.4.6.4. Strategic Initiatives
    • 9.4.7. Cell and Gene Therapy Catapult
      • 9.4.7.1. Overview
      • 9.4.7.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 9.4.7.3. Product Benchmarking
      • 9.4.7.4. Strategic Initiatives
    • 9.4.8. Eurofins Genomics
      • 9.4.8.1. Overview
      • 9.4.8.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 9.4.8.3. Product Benchmarking
      • 9.4.8.4. Strategic Initiatives
    • 9.4.9. Luminous BioSciences, LLC
      • 9.4.9.1. Overview
      • 9.4.9.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 9.4.9.3. Product Benchmarking
      • 9.4.9.4. Strategic Initiatives
    • 9.4.10. Akron Biotech
      • 9.4.10.1. Overview
      • 9.4.10.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 9.4.10.3. Product Benchmarking
      • 9.4.10.4. Strategic Initiatives

List of Tables

  • Table 1 List Of Secondary Sources
  • Table 2 List Of Abbreviations
  • Table 3 Global Plasmid DNA Manufacturing Market by Grade, 2018 - 2030 (USD Million)
  • Table 4 Global Plasmid DNA Manufacturing Market by Development Phase, 2018 - 2030 (USD Million)
  • Table 5 Global Plasmid DNA Manufacturing Market by Application, 2018 - 2030 (USD Million)
  • Table 6 Global Plasmid DNA Manufacturing Market by Disease, 2018 - 2030 (USD Million)
  • Table 7 North America Plasmid DNA Manufacturing Market by Grade, 2018 - 2030 (USD Million)
  • Table 8 North America Plasmid DNA Manufacturing Market by Development Phase, 2018 - 2030 (USD Million)
  • Table 9 North America Plasmid DNA Manufacturing Market by Application, 2018 - 2030 (USD Million)
  • Table 10 North America Plasmid DNA Manufacturing Market by Disease, 2018 - 2030 (USD Million)
  • Table 11 North America Plasmid DNA Manufacturing Market by Country, 2018 - 2030 (USD Million)
  • Table 12 U.S. Plasmid DNA Manufacturing Market by Grade, 2018 - 2030 (USD Million)
  • Table 13 U.S. Plasmid DNA Manufacturing Market by Development Phase, 2018 - 2030 (USD Million)
  • Table 14 U.S. Plasmid DNA Manufacturing Market by Application, 2018 - 2030 (USD Million)
  • Table 15 U.S. Plasmid DNA Manufacturing Market by Disease, 2018 - 2030 (USD Million)
  • Table 16 Canada Plasmid DNA Manufacturing Market by Development Phase, 2018 - 2030 (USD Million)
  • Table 17 Canada Plasmid DNA Manufacturing Market by Development Phase, 2018 - 2030 (USD Million)
  • Table 18 Canada Plasmid DNA Manufacturing Market by Application, 2018 - 2030 (USD Million)
  • Table 19 Canada Plasmid DNA Manufacturing Market by Disease, 2018 - 2030 (USD Million)
  • Table 20 Europe Plasmid DNA Manufacturing Market by Grade, 2018 - 2030 (USD Million)
  • Table 21 Europe Plasmid DNA Manufacturing Market by Development Phase, 2018 - 2030 (USD Million)
  • Table 22 Europe Plasmid DNA Manufacturing Market by Application, 2018 - 2030 (USD Million)
  • Table 23 Europe Plasmid DNA Manufacturing Market by Disease, 2018 - 2030 (USD Million)
  • Table 24 Europe Plasmid DNA Manufacturing Market by Country, 2018 - 2030 (USD Million)
  • Table 25 UK Plasmid DNA Manufacturing Market by Grade, 2018 - 2030 (USD Million)
  • Table 26 UK Plasmid DNA Manufacturing Market by Development Phase, 2018 - 2030 (USD Million)
  • Table 27 UK Plasmid DNA Manufacturing Market by Application, 2018 - 2030 (USD Million)
  • Table 28 UK Plasmid DNA Manufacturing Market by Disease, 2018 - 2030 (USD Million)
  • Table 29 Germany Plasmid DNA Manufacturing Market by Grade, 2018 - 2030 (USD Million)
  • Table 30 Germany Plasmid DNA Manufacturing Market by Development Phase, 2018 - 2030 (USD Million)
  • Table 31 Germany Plasmid DNA Manufacturing Market by Application, 2018 - 2030 (USD Million)
  • Table 32 Germany Plasmid DNA Manufacturing Market by Disease, 2018 - 2030 (USD Million)
  • Table 33 France Plasmid DNA Manufacturing Market by Grade, 2018 - 2030 (USD Million)
  • Table 34 France Plasmid DNA Manufacturing Market by Development Phase, 2018 - 2030 (USD Million)
  • Table 35 France Plasmid DNA Manufacturing Market by Application, 2018 - 2030 (USD Million)
  • Table 36 France Plasmid DNA Manufacturing Market by Disease, 2018 - 2030 (USD Million)
  • Table 37 Italy Plasmid DNA Manufacturing Market by Grade, 2018 - 2030 (USD Million)
  • Table 38 Italy Plasmid DNA Manufacturing Market by Development Phase, 2018 - 2030 (USD Million)
  • Table 39 Italy Plasmid DNA Manufacturing Market by Application, 2018 - 2030 (USD Million)
  • Table 40 Italy Plasmid DNA Manufacturing Market by Disease, 2018 - 2030 (USD Million)
  • Table 41 Spain Plasmid DNA Manufacturing Market by Grade, 2018 - 2030 (USD Million)
  • Table 42 Spain Plasmid DNA Manufacturing Market by Development Phase, 2018 - 2030 (USD Million)
  • Table 43 Spain Plasmid DNA Manufacturing Market by Application, 2018 - 2030 (USD Million)
  • Table 44 Spain Plasmid DNA Manufacturing Market by Disease, 2018 - 2030 (USD Million)
  • Table 45 Denmark Plasmid DNA Manufacturing Market by Grade, 2018 - 2030 (USD Million)
  • Table 46 Denmark Plasmid DNA Manufacturing Market by Development Phase, 2018 - 2030 (USD Million)
  • Table 47 Denmark Plasmid DNA Manufacturing Market by Application, 2018 - 2030 (USD Million)
  • Table 48 Denmark Plasmid DNA Manufacturing Market by Disease, 2018 - 2030 (USD Million)
  • Table 49 Sweden Plasmid DNA Manufacturing Market by Grade, 2018 - 2030 (USD Million)
  • Table 50 Sweden Plasmid DNA Manufacturing Market by Development Phase, 2018 - 2030 (USD Million)
  • Table 51 Sweden Plasmid DNA Manufacturing Market by Application, 2018 - 2030 (USD Million)
  • Table 52 Sweden Plasmid DNA Manufacturing Market by Disease, 2018 - 2030 (USD Million)
  • Table 53 Norway Plasmid DNA Manufacturing Market by Grade, 2018 - 2030 (USD Million)
  • Table 54 Norway Plasmid DNA Manufacturing Market by Development Phase, 2018 - 2030 (USD Million)
  • Table 55 Norway Plasmid DNA Manufacturing Market by Application, 2018 - 2030 (USD Million)
  • Table 56 Norway Plasmid DNA Manufacturing Market by Disease, 2018 - 2030 (USD Million)
  • Table 57 Asia Pacific Plasmid DNA Manufacturing Market by Grade, 2018 - 2030 (USD Million)
  • Table 58 Asia Pacific Plasmid DNA Manufacturing Market by Development Phase, 2018 - 2030 (USD Million)
  • Table 59 Asia Pacific Plasmid DNA Manufacturing Market by Application, 2018 - 2030 (USD Million)
  • Table 60 Asia Pacific Plasmid DNA Manufacturing Market by Disease, 2018 - 2030 (USD Million)
  • Table 61 Asia Pacific Plasmid DNA Manufacturing Market by Country, 2018 - 2030 (USD Million)
  • Table 62 China Plasmid DNA Manufacturing Market by Grade, 2018 - 2030 (USD Million)
  • Table 63 China Plasmid DNA Manufacturing Market by Development Phase, 2018 - 2030 (USD Million)
  • Table 64 China Plasmid DNA Manufacturing Market by Application, 2018 - 2030 (USD Million)
  • Table 65 China Plasmid DNA Manufacturing Market by Disease, 2018 - 2030 (USD Million)
  • Table 66 Japan Plasmid DNA Manufacturing Market by Grade, 2018 - 2030 (USD Million)
  • Table 67 Japan Plasmid DNA Manufacturing Market by Development Phase, 2018 - 2030 (USD Million)
  • Table 68 Japan Plasmid DNA Manufacturing Market by Application, 2018 - 2030 (USD Million)
  • Table 69 Japan Plasmid DNA Manufacturing Market by Disease, 2018 - 2030 (USD Million)
  • Table 70 India Plasmid DNA Manufacturing Market by Grade, 2018 - 2030 (USD Million)
  • Table 71 India Plasmid DNA Manufacturing Market by Development Phase, 2018 - 2030 (USD Million)
  • Table 72 India Plasmid DNA Manufacturing Market by Application, 2018 - 2030 (USD Million)
  • Table 73 India Plasmid DNA Manufacturing Market by Disease, 2018 - 2030 (USD Million)
  • Table 74 South Korea Plasmid DNA Manufacturing Market by Grade, 2018 - 2030 (USD Million)
  • Table 75 South Korea Plasmid DNA Manufacturing Market by Development Phase, 2018 - 2030 (USD Million)
  • Table 76 South Korea Plasmid DNA Manufacturing Market by Application, 2018 - 2030 (USD Million)
  • Table 77 South Korea Plasmid DNA Manufacturing Market by Disease, 2018 - 2030 (USD Million)
  • Table 78 Australia Plasmid DNA Manufacturing Market by Grade, 2018 - 2030 (USD Million)
  • Table 79 Australia Plasmid DNA Manufacturing Market by Development Phase, 2018 - 2030 (USD Million)
  • Table 80 Australia Plasmid DNA Manufacturing Market by Application, 2018 - 2030 (USD Million)
  • Table 81 Australia Plasmid DNA Manufacturing Market by Disease, 2018 - 2030 (USD Million)
  • Table 82 Thailand Plasmid DNA Manufacturing Market by Grade, 2018 - 2030 (USD Million)
  • Table 83 Thailand Plasmid DNA Manufacturing Market by Development Phase, 2018 - 2030 (USD Million)
  • Table 84 Thailand Plasmid DNA Manufacturing Market by Application, 2018 - 2030 (USD Million)
  • Table 85 Thailand Plasmid DNA Manufacturing Market by Disease, 2018 - 2030 (USD Million)
  • Table 86 Latin America Plasmid DNA Manufacturing Market by Grade, 2018 - 2030 (USD Million)
  • Table 87 Latin America Plasmid DNA Manufacturing Market by Development Phase, 2018 - 2030 (USD Million)
  • Table 88 Latin America Plasmid DNA Manufacturing Market by Application, 2018 - 2030 (USD Million)
  • Table 89 Latin America Plasmid DNA Manufacturing Market by Disease, 2018 - 2030 (USD Million)
  • Table 90 Latin America Plasmid DNA Manufacturing Market by Country, 2018 - 2030 (USD Million)
  • Table 91 Brazil Plasmid DNA Manufacturing Market by Grade, 2018 - 2030 (USD Million)
  • Table 92 Brazil Plasmid DNA Manufacturing Market by Development Phase, 2018 - 2030 (USD Million)
  • Table 93 Brazil Plasmid DNA Manufacturing Market by Application, 2018 - 2030 (USD Million)
  • Table 94 Brazil Plasmid DNA Manufacturing Market by Disease, 2018 - 2030 (USD Million)
  • Table 95 Mexico Plasmid DNA Manufacturing Market by Grade, 2018 - 2030 (USD Million)
  • Table 96 Mexico Plasmid DNA Manufacturing Market by Development Phase, 2018 - 2030 (USD Million)
  • Table 97 Mexico Plasmid DNA Manufacturing Market by Application, 2018 - 2030 (USD Million)
  • Table 98 Mexico Plasmid DNA Manufacturing Market by Disease, 2018 - 2030 (USD Million)
  • Table 99 Argentina Plasmid DNA Manufacturing Market by Grade, 2018 - 2030 (USD Million)
  • Table 100 Argentina Plasmid DNA Manufacturing Market by Development Phase, 2018 - 2030 (USD Million)
  • Table 101 Argentina Plasmid DNA Manufacturing Market by Application, 2018 - 2030 (USD Million)
  • Table 102 Argentina Plasmid DNA Manufacturing Market by Disease, 2018 - 2030 (USD Million)
  • Table 103 Middle East & Africa Plasmid DNA Manufacturing Market by Grade, 2018 - 2030 (USD Million)
  • Table 104 Middle East & Africa Plasmid DNA Manufacturing Market by Development Phase, 2018 - 2030 (USD Million)
  • Table 105 Middle East & Africa Plasmid DNA Manufacturing Market by Application, 2018 - 2030 (USD Million)
  • Table 106 Middle East & Africa Plasmid DNA Manufacturing Market by Disease, 2018 - 2030 (USD Million)
  • Table 107 Middle East & Africa Plasmid DNA Manufacturing Market by Country, 2018 - 2030 (USD Million)
  • Table 108 South Africa Plasmid DNA Manufacturing Market by Grade, 2018 - 2030 (USD Million)
  • Table 109 South Africa Plasmid DNA Manufacturing Market by Development Phase, 2018 - 2030 (USD Million)
  • Table 110 South Africa Plasmid DNA Manufacturing Market by Application, 2018 - 2030 (USD Million)
  • Table 111 South Africa Plasmid DNA Manufacturing Market by Disease, 2018 - 2030 (USD Million)
  • Table 112 Saudi Arabia Plasmid DNA Manufacturing Market by Grade, 2018 - 2030 (USD Million)
  • Table 113 Saudi Arabia Plasmid DNA Manufacturing Market by Development Phase, 2018 - 2030 (USD Million)
  • Table 114 Saudi Arabia Plasmid DNA Manufacturing Market by Application, 2018 - 2030 (USD Million)
  • Table 115 Saudi Arabia Plasmid DNA Manufacturing Market by Disease, 2018 - 2030 (USD Million)
  • Table 116 UAE Plasmid DNA Manufacturing Market by Grade, 2018 - 2030 (USD Million)
  • Table 117 UAE Plasmid DNA Manufacturing Market by Development Phase, 2018 - 2030 (USD Million)
  • Table 118 UAE Plasmid DNA Manufacturing Market by Application, 2018 - 2030 (USD Million)
  • Table 119 UAE Plasmid DNA Manufacturing Market by Disease, 2018 - 2030 (USD Million)
  • Table 120 Kuwait Plasmid DNA Manufacturing Market by Grade, 2018 - 2030 (USD Million)
  • Table 121 Kuwait Plasmid DNA Manufacturing Market by Development Phase, 2018 - 2030 (USD Million)
  • Table 122 Kuwait Plasmid DNA Manufacturing Market By Application, 2018 - 2030 (USD Million)
  • Table 123 Kuwait Plasmid DNA Manufacturing Market by Disease, 2018 - 2030 (USD Million)
  • Table 124 Participant's Overview
  • Table 125 Financial Performance
  • Table 126 Key Companies Undergoing Expansions
  • Table 127 Key Companies Undergoing Acquisitions
  • Table 128 Key Companies Undergoing Collaborations
  • Table 129 Key Companies Launching New Products/Services
  • Table 130 Key Companies Undergoing Partnerships
  • Table 131 Key Companies Undertaking Other Strategies

List of Figures

  • Figure 1. Market Others process
  • Figure 2. Data triangulation techniques
  • Figure 3. Primary Others pattern
  • Figure 4. Market Others approaches
  • Figure 5. Value-chain-based sizing & forecasting
  • Figure 6. QFD modeling for market share assessment
  • Figure 7. Market formulation & validation
  • Figure 8. Market summary, 2023 (USD Million)
  • Figure 9. Market segmentation & scope
  • Figure 10. Market driver impact
  • Figure 11. Market restraint impact
  • Figure 12. Penetration & growth prospect mapping
  • Figure 13. Porter's analysis
  • Figure 14. SWOT analysis
  • Figure 15. Global plasmid DNA manufacturing market: Grade outlook and key takeaways
  • Figure 16. Global plasmid DNA manufacturing market: Grade movement analysis
  • Figure 17. Global R&D grade market, 2018 - 2030 (USD Million)
  • Figure 18. Global GMP grade market, 2018 - 2030 (USD Million)
  • Figure 19. Global plasmid DNA manufacturing market: Development phase outlook and key takeaways
  • Figure 20. Global plasmid DNA manufacturing market: Development phase movement analysis
  • Figure 21. Global pre-clinical therapeutics market, 2018 - 2030 (USD Million)
  • Figure 22. Global clinical therapeutics market, 2018 - 2030 (USD Million)
  • Figure 23. Global marketed therapeutics market, 2018 - 2030 (USD Million)
  • Figure 24. Global plasmid DNA manufacturing market: Application outlook and key takeaways
  • Figure 25. Global plasmid DNA manufacturing market: Application movement analysis
  • Figure 26. Global DNA vaccines market, 2018 - 2030 (USD Million)
  • Figure 27. Global cell & gene therapy market, 2018 - 2030 (USD Million)
  • Figure 28. Global immunotherapy market, 2018 - 2030 (USD Million)
  • Figure 29. Global others market, 2018 - 2030 (USD Million)
  • Figure 30. Global plasmid DNA manufacturing market: Disease outlook and key takeaways
  • Figure 31. Global plasmid DNA manufacturing market: Disease movement analysis
  • Figure 32. Global infectious disease market, 2018 - 2030 (USD Million)
  • Figure 33. Global cancer market, 2018 - 2030 (USD Million)
  • Figure 34. Global genetic disorder market, 2018 - 2030 (USD Million)
  • Figure 35. Global Others market, 2018 - 2030 (USD Million)
  • Figure 36. Global plasmid DNA manufacturing market: Regional outlook and key takeaways
  • Figure 37. North America plasmid DNA manufacturing market, 2018 - 2030 (USD Million)
  • Figure 38. U.S. key country dynamics
  • Figure 39. U.S. plasmid DNA manufacturing market, 2018 - 2030 (USD Million)
  • Figure 40. Canada key country dynamics
  • Figure 41. Canada plasmid DNA manufacturing market, 2018 - 2030 (USD Million)
  • Figure 42. Europe plasmid DNA manufacturing market estimates and forecast, 2018 - 2030 (USD Million)
  • Figure 43. Germany key country dynamics
  • Figure 44. Germany plasmid DNA manufacturing market estimates and forecast, 2018 - 2030 (USD Million)
  • Figure 45. France key country dynamics
  • Figure 46. France plasmid DNA manufacturing market estimates and forecast, 2018 - 2030 (USD Million)
  • Figure 47. UK key country dynamics
  • Figure 48. UK plasmid DNA manufacturing market estimates and forecast, 2018 - 2030 (USD Million)
  • Figure 49. Italy key country dynamics
  • Figure 50. Italy plasmid DNA manufacturing market estimates and forecast, 2018 - 2030 (USD Million)
  • Figure 51. Spain key country dynamics
  • Figure 52. Spain plasmid DNA manufacturing market estimates and forecast, 2018 - 2030 (USD Million)
  • Figure 53. Denmark key country dynamics
  • Figure 54. Denmark plasmid DNA manufacturing market estimates and forecast, 2018 - 2030 (USD Million)
  • Figure 55. Sweden key country dynamics
  • Figure 56. Sweden plasmid DNA manufacturing market estimates and forecast, 2018 - 2030 (USD Million)
  • Figure 57. Norway key country dynamics
  • Figure 58. Norway plasmid DNA manufacturing market estimates and forecast, 2018 - 2030 (USD Million)
  • Figure 59. Asia-Pacific plasmid DNA manufacturing market estimates and forecast, 2018 - 2030 (USD Million)
  • Figure 60. China key country dynamics
  • Figure 61. China plasmid DNA manufacturing market estimates and forecast, 2018 - 2030 (USD Million)
  • Figure 62. India key country dynamics
  • Figure 63. India plasmid DNA manufacturing market estimates and forecast, 2018 - 2030 (USD Million)
  • Figure 64. South Korea key country dynamics
  • Figure 65. South Korea plasmid DNA manufacturing market estimates and forecast, 2018 - 2030 (USD Million)
  • Figure 66. Japan key country dynamics
  • Figure 67. Japan plasmid DNA manufacturing market estimates and forecast, 2018 - 2030 (USD Million)
  • Figure 68. Australia key country dynamics
  • Figure 69. Australia plasmid DNA manufacturing market estimates and forecast, 2018 - 2030 (USD Million)
  • Figure 70. Thailand key country dynamics
  • Figure 71. Thailand plasmid DNA manufacturing market estimates and forecast, 2018 - 2030 (USD Million)
  • Figure 72. Latin America plasmid DNA manufacturing market estimates and forecast, 2018 - 2030 (USD Million)
  • Figure 73. Brazil key country dynamics
  • Figure 74. Brazil plasmid DNA manufacturing market estimates and forecast, 2018 - 2030 (USD Million)
  • Figure 75. Mexico key country dynamics
  • Figure 76. Mexico plasmid DNA manufacturing market estimates and forecast, 2018 - 2030 (USD Million)
  • Figure 77. Argentina key country dynamics
  • Figure 78. Argentina plasmid DNA manufacturing market estimates and forecast, 2018 - 2030 (USD Million)
  • Figure 79. MEA plasmid DNA manufacturing market estimates and forecast, 2018 - 2030 (USD Million)
  • Figure 80. South Africa key country dynamics
  • Figure 81. South Africa plasmid DNA manufacturing market estimates and forecast, 2018 - 2030 (USD Million)
  • Figure 82. Saudi Arabia key country dynamics
  • Figure 83. Saudi Arabia plasmid DNA manufacturing market estimates and forecast, 2018 - 2030 (USD Million)
  • Figure 84. UAE key country dynamics
  • Figure 85. UAE plasmid DNA manufacturing market estimates and forecast, 2018 - 2030 (USD Million)
  • Figure 86. Kuwait key country dynamics
  • Figure 87. Kuwait plasmid DNA manufacturing market estimates and forecast, 2018 - 2030 (USD Million)
  • Figure 88. Market participant categorization
  • Figure 89. Plasmid DNA manufacturing market share analysis, 2023
  • Figure 90. Strategy framework